[Treatment of acute intermittent porphyria].
D000208:Acute Disease; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D001794:Blood Pressure / Q000187:drug effects; D001815:Bloodletting; D003574:Cytochrome c Group / Q000627:therapeutic use; D004035:Diet Therapy; D005078:Exchange Transfusion, Whole Blood; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006801:Humans; D008110:Liver Extracts / Q000627:therapeutic use; D008297:Male; D008353:Mannitol / Q000627:therapeutic use; D011164:Porphyrias / Q000188:drug therapy / Q000628:therapy*; D011736:Pyridoxine / Q000627:therapeutic use; D006435:Renal Dialysis
D000319:Adrenergic beta-Antagonists; D003574:Cytochrome c Group; D008110:Liver Extracts; D008353:Mannitol; D011736:Pyridoxine
Leczenie ostrej porfirii przerywanej.